年龄相关性黄斑变性脉络膜新生血管在无治疗期复发性渗出的预测因素
本研究回顾性分析41例接受抗VEGF治疗超过3年的新生血管性年龄相关性黄斑变性患眼,在无治疗期超过6个月后随访6个月。结果显示,复发组CNV面积平方根显著增大(P=0.036),且分支伴微小血管(42%)和CNV末端周边弓(42%)比例显著高于无复发组(14%和5%,P<0.001)。
要点
- CNV面积增大是无治疗期复发性渗出的预测因素
- 分支伴微小血管和CNV末端周边弓与复发显著相关
- CNV扩大和特征可指导无渗出期患眼的治疗时机
核心结论
- 脉络膜新生血管扩大及其特征可能指导无渗出期患眼的治疗时机。
研究设计与样本
- 回顾性研究纳入41例41眼有超过3年抗VEGF治疗史的新生血管性年龄相关性黄斑变性患眼,基线后无治疗期超过6个月并按需治疗,随访6个月。
主要发现
- 19眼在第二个6个月期间复发,其CNV面积平方根在无治疗期从2.31±0.81 mm显著增大至2.86±0.87 mm(P=0.036),22眼无复发者未增大。
- 复发组分支伴微小血管比例为42%,显著高于无活动组的14%(P<0.001)。
- 复发组CNV末端周边弓比例为42%,显著高于无活动组的5%(P<0.001)。
临床怎么用
- 对于无渗出期的nAMD患眼,可关注OCTA上CNV面积变化及分支伴微小血管、末端周边弓等特征,辅助判断治疗时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate predictors of recurrent exudation in choroidal neovascularization (CNV) of age-related macular degeneration on optical coherence tomography angiography (OCTA) images during an anti-vascular endothelium growth factor therapy-free period. METHODS: Optical coherence tomography angiography images of 41 eyes of 41 patients with more than a 3-year history of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration at the study baseline were evaluated retrospectively. The patients thereafter had a treatment-free period exceeding 6 months under an as-needed regimen and could be followed for an additional 6 months. RESULTS: The square root of the CNV area in 19 eyes with recurrence during the second 6-month period enlarged significantly (P = 0.036) from 2.31 ± 0.81 (mean ± SD) to 2.86 ± 0.87 mm during the treatment-free period but not in the 22 eyes without a recurrence. The percentages of branching with tiny vessels (42%) and peripheral arcades at the CNV termini (42%) were significantly (P < 0.001, respectively) higher in the recurrence group compared with the group in which the CNV was no longer active (14% and 5%, respectively). CONCLUSION: Choroidal neovascularization enlargement and features may guide treatment timing in eyes with exudative-free periods.
引用
- Hikichi T, Agarie M, Kubo N, et al. PREDICTORS OF RECURRENT EXUDATION IN CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION DURING A TREATMENT-FREE PERIOD. Retina. 2020. PMID: 31922495. doi:10.1097/IAE.0000000000002745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。